MedTrace Logo

Study to Evaluate Satisfaction After Treatment With Kysse

NCT03967444 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2022-08-26

Study results available
· View outcomes & findings →

Summary

Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Kysse.

Conditions

  • Lip Augmentation

Interventions

DEVICE

Hyaluronic acid

Injectable gel for lip augmentation

DEVICE

Hyaluronic acid

Injectable gel. Lip Augmentation and other wrinkles/folds

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Study Director · Galderma R&D

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-29
Primary Completion
2019-09-18
Completion
2019-09-18

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03967444 on ClinicalTrials.gov